Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03FSU
|
||||
Former ID |
DIB008189
|
||||
Drug Name |
Concatameric CTLA4Ig
|
||||
Synonyms |
Concatameric CTLA4Ig (Immunoadhesin); Concatameric CD152Ig (Immunoadhesin), Medexgen; Concatameric CTLA4Ig (Immunoadhesin), Medexgen
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Company |
Medexgen Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Cytotoxic T-lymphocyte protein 4 | Target Info | Modulator | [1] | |
KEGG Pathway | Cell adhesion molecules (CAMs) | ||||
T cell receptor signaling pathway | |||||
Autoimmune thyroid disease | |||||
Rheumatoid arthritis | |||||
Pathway Interaction Database | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | ||||
Reactome | CTLA4 inhibitory signaling | ||||
WikiPathways | Vitamin D Receptor Pathway | ||||
T-Cell Receptor and Co-stimulatory Signaling | |||||
Allograft Rejection | |||||
Costimulation by the CD28 family | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2743). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.